CenterBook Partners’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$694K Buy
+5,051
New +$694K 0.04% 383
2025
Q1
Sell
-4,283
Closed -$671K 544
2024
Q4
$671K Buy
+4,283
New +$671K 0.04% 385
2024
Q1
Sell
-5,335
Closed -$662K 440
2023
Q4
$662K Buy
5,335
+1,020
+24% +$127K 0.08% 298
2023
Q3
$501K Buy
+4,315
New +$501K 0.06% 325